| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |